Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Leukemia|April 29, 2022
MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphomaWenping Zhou, Yuanlin Xu, Jiuyang Zhang, et al.
Biomarker Research|September 1, 2020
A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progressionJialin Ma, Zheng Yan, Jiuyang Zhang, et al.
Scientific Data|May 29, 2026
An open multi-center MEG-EEG dataset for studying conscious visual perceptionLing Liu, Oscar Ferrante, Tara Ghafari, et al.
The Plant Journal : for Cell and Molecular Biology|October 13, 2020
Activation tagging identifies Arabidopsis transcription factor AtMYB68 for heat and drought tolerance at yield determining reproductive stagesMingde Deng, Yang Wang, Monika Kuzma, et al.
Plos One|November 25, 2015
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER studyYuankai Shi, Junling Li, Shucai Zhang, et al.
Frontiers in Immunology|August 28, 2020
Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell TransplantationLixia Sheng, Qitian Mu, Xiaoqing Wu, et al.
Future Oncology (London, England)|May 28, 2026
Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from ChinaZhiqiang Wang, Haijun Zhong, Yifu He, et al.
The Oncologist|April 20, 2024
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practiceJin Li, Zhiqiang Wang, Haijun Zhong, et al.
Therapeutic Advances in Medical Oncology|September 4, 2025
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice studyYi Wang, Yifu He, Zhiqiang Wang, et al.
Nature Medicine|February 1, 2024
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 studyJin Li, Zhendong Chen, Yuxian Bai, et al.
Pageof 14